Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2016 Nov 5, 2015
Oculus Innovative Sciences Announces Fiscal Second Quarter 2016 Financial Results and Conference Call Oct 22, 2015
Oculus Innovative Sciences Introduces MicrocynAH(R) Next-Generation Dermatology Products With Dimethicone for Animals Sep 24, 2015
Oculus Innovative Sciences Announces Preliminary Results for Its 2015 Annual Meeting of Stockholders Sep 11, 2015
Oculus Innovative Sciences Announces Introduction of Alevicyn SG Antipruritic Spray Gel for Relief of Pain and Itch in Atopic Dermatitis Aug 19, 2015
Oculus Innovative Sciences Reports Financial Results for the First Quarter of Fiscal Year 2016 Jul 30, 2015
Oculus Innovative Sciences Announces Fiscal First Quarter 2016 Financial Results and Conference Call Jul 16, 2015
Oculus Innovative Sciences Receives New U.S. Patent for Microcyn(R) Technology in Treatment of Atopic Dermatitis Jul 8, 2015
Oculus Innovative Sciences Announces Sale of 1.65 Million Shares of Ruthigen Stock for $4.5 Million in Non-Dilutive Funding Jun 16, 2015
